Terence A. Kelly
Director
Biomedical
CARDAX COMPANY
Haiti
Biography
Dr. Kelly is a scientific leader with both Pharma and Biotech experience and a track record of delivering high quality compounds into advanced clinical studies. He is well versed in chemistry, disease biology and the enabling technologies needed for innovative and efficient drug discovery from lead identification through clinical development. In particular, he has extensive hands on drug discovery and development experience in Inflammation, Cardiovascular and CNS disorders. Dr. Kelly has served as a director of Cardax, Inc. since June 2014. Dr. Kelly is a founder of Kelly Pharma Research Consulting, LLC. Between 1990 and 2009, Dr. Kelly served in various scientific and executive positions at Boehringer Ingelheim, where after a successful early career developing LFA-1 antagonists, he led its US-based medicinal chemistry department comprising145 scientists in the high throughput screening, computational chemistry, structural biology, combinatorial chemistry and medicinal chemistry groups.
Research Interest
bioinformatics
